Biotransformation enzymes in two renal epithelial cell lines (LLC-PK1 and RK-L)
- PMID: 3509689
Biotransformation enzymes in two renal epithelial cell lines (LLC-PK1 and RK-L)
Abstract
The activities of smooth endoplasmic reticulum (SER) and cytosolic xenobiotic-metabolizing enzymes were studied in two established renal tubular cell lines, LLC-PK1 and RK-L (rat kidney, Lübeck). The glutathione content in both cell lines was about 20-fold higher than in rat kidney homogenates; this is explained by a 20- to 50-fold lower activity of gamma-glutamyl transpeptidase in the cell lines. Among SER enzymes, the cytochrome P-450-dependent dimethylhydrazine demethylase was in the same range in both cell lines as compared with rat kidney S9 fraction. Pretreatment with phenobarbital (0.1 mM in the culture medium for 3 d) did not induce SER or cytosolic enzyme activities. The glutathione content in both epithelial cell lines can be modified by an inhibitor of GSH synthesis (buthionine sulfoximine, BSO), whereas inhibition of gamma-glutamyl transpeptidase (acivicin) did not significantly increase the GSH-concentration. Despite these biochemical characteristics, the utility of the new RK-L-line needs to be evaluated in experimental studies on renal transport processes and metabolism as well as cytotoxicity and genotoxicity of xenobiotics.
Similar articles
-
Induction of microvillar hydrolase activities by cell density and exogenous differentiation inducers in an established kidney epithelial cell line (LLC-PK1).J Cell Physiol. 1984 Oct;121(1):64-73. doi: 10.1002/jcp.1041210109. J Cell Physiol. 1984. PMID: 6090480
-
Sensitive enzymatic cycling assay for glutathione: measurements of glutathione content and its modulation by buthionine sulfoximine in vivo and in vitro in human colon cancer.Cancer Res. 1994 Aug 1;54(15):4077-83. Cancer Res. 1994. PMID: 8033140
-
Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells.Mol Pharmacol. 1996 Jun;49(6):1012-20. Mol Pharmacol. 1996. PMID: 8649339
-
Expression and activities of several drug-metabolizing enzymes in LLC-PK1 cells.Toxicol In Vitro. 2004 Dec;18(6):887-94. doi: 10.1016/j.tiv.2004.05.001. Toxicol In Vitro. 2004. PMID: 15465656
-
Xenobiotic metabolizing enzymes of the kidney.Toxicol Pathol. 1998 Jan-Feb;26(1):18-25. doi: 10.1177/019262339802600102. Toxicol Pathol. 1998. PMID: 9502382 Review.
Cited by
-
Establishment and characterization of the transformants stably-expressing MDR1 derived from various animal species in LLC-PK1.Pharm Res. 2006 Jul;23(7):1460-72. doi: 10.1007/s11095-006-0285-7. Epub 2006 Jun 21. Pharm Res. 2006. PMID: 16779700
-
Dithio-bis-mercaptoethanesulphonate (DIMESNA) does not prevent cellular damage by metabolites of ifosfamide and cyclophosphamide in LLC-PK1 cells.Pediatr Nephrol. 1994 Aug;8(4):458-65. doi: 10.1007/BF00856531. Pediatr Nephrol. 1994. PMID: 7524598